The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.

Area of Science:

• Neurology
• Vascular Biology
• Pathophysiology

Background:

• Hypoxia (oxygen deprivation) is increasingly recognized as a factor in early multiple sclerosis (MS) lesion development.
• Evidence includes elevated hypoxia-inducible factors and genes in MS lesions and adjacent white matter.
• Reduced white matter blood flow correlates with increased lesion probability.

Purpose of the Study:

• To explore the role of hypoxia and hypoperfusion in the pathogenesis of early MS lesions.
• To investigate the interplay between vascular factors, genetic predisposition, and MS lesion formation.
• To propose considerations for clinical trials involving vascular interventions in MS.

Main Methods:

• Review of evidence linking hypoxia-inducible factors and gene expression to MS lesions.
• Analysis of studies showing reduced white matter perfusion in MS patients.
• Examination of the potential causes of hypoperfusion, including venous and arterial factors.

Main Results:

• Increased hypoxia-inducible factor-1 α and related gene expression observed in MS lesions and normal-appearing white matter (NAWM).
• Significant reduction (50%) in blood flow through NAWM, with lowest flow areas showing highest lesion development probability.
• Hypoperfusion may stem from decreased arterial supply or restricted venous return, potentially linked to chronic cerebrospinal venous insufficiency (CCSVI).

Conclusions:

• Hypoxia is a significant precipitating factor in early MS lesion formation.
• Genetic factors likely mediate individual susceptibility to MS-like lesions following hypoxemic insults.
• Clinical trials for vascular interventions in MS should assess impacts on white matter perfusion and functional recovery, considering both venous and arterial contributions.